MIVA Medical Partners With Kansas City Radio Station KPRS to Educate Women About Uterine Fibroids

Dec 30, 2022

The new partnership educates a culturally diverse audience about uterine fibroids

Press Release- Dec 13, 2022

KANSAS CITY, Mo., December 13, 2022 (Newswire.com) – MIVA Medical, the leading endovascular treatment center in the greater Kansas City Metro area, is pleased to announce a new marketing partnership with Kansas City’s #1 Hip Hop and R&B radio station KPRS HOT 103 JAMZ.

The new partnership between MIVA Medical and KPRS Hot 103 JAMZ provides an important opportunity for MIVA Medical and the radio station to educate a culturally diverse audience about uterine fibroids; a common condition found in women aged 25-54. Uterine Fibroids are non-cancerous tumors found on the uterus and often are very painful and cause excessive bleeding during menstrual cycles. 

“There is a lot to know about uterine fibroids and the treatment options available. We want women in the Kansas City community to know about their treatment choices when it comes to uterine fibroids which are 5x’s more commonly found in African American women and 3x’s more prevalent in Hispanic women,” says Board Certified and Fellowship TrainedInterventional Radiologist Dr. Silas Williams.

“When we heard about what MIVA Medical wanted to do we felt it was important to help our listeners become more educated about this medical condition, so we partnered with MIVA to produce a series of public service announcements called ‘Your Health Matters’ to shine a light on this problem and its treatment options,” said KPRS General Manager Victor Dyson. 

MIVA Medical made the decision to team with KPRS Hot 103 JAMZ because its radio station is known to reach an ethnically diverse audience of loyal listeners and is the #1 Urban station delivering women 25-54 all week long. When Hot 103 JAMZ listeners tune in to their favorite radio station they will hear a series of interview segments with Dr. Williams answering most asked questions like “what are uterine fibroids?” How are they diagnosed? What are the symptoms? What treatment options are available besides surgery? And, how does the minimally invasive treatment called Uterine Fibroid Embolization compare to a Hysterectomy?  

“Most people are not familiar with interventional radiology as a specialty and the broad range of medical conditions we treat. Thanks to advancements in x-ray and imaging technology, we can navigate inside the body and treat conditions such as uterine fibroids without the need for open surgery. It’s important to help folks understand every option out there and KPRS Kansas City offered us the broadest way to reach women most at risk of developing uterine fibroids” said endovascular specialist Dr. Silas Williams.

Listeners can also find information on the KPRS.com web page where they can click a banner for more info about uterine fibroids taking them to more information and videos at miva-medical.com. There is even a quiz listeners can take at https://miva-medical.com/uterine-fibroids to learn more. 

ABOUT MIVA Medical

MIVA Medical (www.miva-medical.com) is an office-based lab that focuses on interventional radiology and minimally invasive options for a variety of patient conditions – including oncology, wounds, leg pain, fibroids, and osteoarthritis. MIVA is dedicated to staying on top and in front of the most exciting advances in treatments for a variety of women’s and men’s health issues with a strong focus on lower extremity arterial disease and liver cancer therapies. MIVA works collaboratively with referring physician colleagues and takes a patient-centric approach to endovascular care. They are committed to the highest level of patient care in a safe, comfortable outpatient setting.